Top Markets
Coin of the day
Valeo Pharma Inc. Valeo Pharma Inc.

Valeo Pharma Inc.

VPHIF
Rank in Stocks #41805
Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to... Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its extensive product lineup features prominent asthma medications like Enerzair Breezhaler (a triple-combination LABA/LAMA/ICS) and Atectura Breezhaler (a dual-combination LABA/ICS). The company also offers Redesca, crucial for preventing and treating deep vein thrombosis and pulmonary embolism. For neurological conditions, Valeo markets Onstryv, an add-on treatment for Idiopathic Parkinson's Disease in patients on stable Levodopa, and Benztropine, an anticholinergic for PD. Pain management is addressed with M-Eslon, an extended-release morphine sulfate, while Yondelis targets soft tissue sarcoma. Beyond these, the portfolio includes Hesperco, an immune-supporting bioflavonoid antioxidant; Ametop, a skin anesthetic used before venous procedures; Ethacrynate Sodium, a loop diuretic for high blood pressure and swelling; and Amikacin, an injectable antibiotic. Founded in 2003, Valeo Pharma Inc. is headquartered in Kirkland, Canada.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$9.87K
Change (1 day)
0.00%
Change (1 year)
-99.79%
Country
CA
Trade Valeo Pharma Inc. (VPHIF)

Category

Stock price history for Valeo Pharma Inc. (VPHIF)
Highest end of day price: $0.00 on 2026-08-01

Lowest end of day price: $0.85 on 2020-09-01
Stock price history of Valeo Pharma Inc. from 2020 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 0.00%
2025 -99.79%
2024 -64.24%
2023 -71.62%
2022 -18.52%
2021 -36.53%
2020 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$166.06 27.73%
DE
$36.27 22.59%
JP
$228.90 41.12%
CH
$21.42 14.21%
IN